Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition.
about
Specificity and sensitivity of glucocorticoid signaling in health and diseaseWeekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trialEffect of folic acid on methotrexate induction of sulfotransferases in rats.Methotrexate: can it be a choice for nasal polyposis in aspirin exacerbated respiratory disease?Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy.
P2860
Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Methotrexate therapy in asthma ...... to corticosteroid inhibition.
@en
Methotrexate therapy in asthma ...... to corticosteroid inhibition.
@nl
type
label
Methotrexate therapy in asthma ...... to corticosteroid inhibition.
@en
Methotrexate therapy in asthma ...... to corticosteroid inhibition.
@nl
prefLabel
Methotrexate therapy in asthma ...... to corticosteroid inhibition.
@en
Methotrexate therapy in asthma ...... to corticosteroid inhibition.
@nl
P2093
P2860
P1476
Methotrexate therapy in asthma ...... y to corticosteroid inhibition
@en
P2093
P2860
P304
P356
10.1046/J.1365-2222.2003.T01-1-01723.X
P577
2003-08-01T00:00:00Z